Ireland
--:--IST
Recruiting Not applicable

Analgesic Efficacy of Different Nerve Blocks in Postoperative Cesarean Section

NCT06088420 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2023-10-15
Last updated
2025-04-09

Condition(s) studied

Post Operative Pain

Investigational drug(s) / intervention(s)

Intrathcal Morphine GroupQuadratus Lumborum nerve block(QL) groupErector Spinae nerve block (ESP)group

Intrathcal Morphine Group: intrathecal morphine (150 μg) in addition to standard spinal anesthetic drugs(10-12 mg 0.5% hyperbaric bupivacaine)

Quadratus Lumborum nerve block(QL) group: intrathecal morphine (150 μg) in addition to standard spinal anesthetic drugs (10-12 mg 0.5% hyperbaric bupivacaine) + bilateral QL block by injecting 20 ml of 0.25% isobaric bupivacaine bolus with 4 mg ) dexamethasone as an adjuvant

Erector Spinae nerve block (ESP)group: intrathecal morphine (150 μg) in addition to standard spinal anesthetic drugs (10-12 mg 0.5% hyperbaric bupivacaine) + bilateral ESP block by injecting 20 ml of 0.25% isobaric bupivacaine bolus with 4 mg ) dexamethasone as an adjuvant

Study summary

comparing analgesic efficacy of different nerve blocks on post operative cesarean sections.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * 18-40 years old * more or equal 37 weeks of gestation * ASA 1,2 * Elective cesarean delivery Exclusion Criteria: * Patient refusal * inability to cooperate with or understand the study * local infection. * bleeding disorder * known anaphylaxis to any drug used in the trial * ASA physical status more than 2 * emergency operations * chronic opioid use (opioid use in the past 3 months) * Neurologic deficit or disorder * contraindication to regional anesthesia.

Primary outcome measure(s)

  • Duration of analgesia until first analgesic request. — 24 hours .
    the time interval from immediate postoperative period until NRS reached 4

Trial sites (1)

FacilityCityRegionStatus
Mahmoud Mamdouh Ekram Asyut Manfalout Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06088420 on ClinicalTrials.gov ↗ ← All trials in Egypt